Natera CEO Says Company Is 'Clearly on a Roll' After Record Test Volumes, Raises Outlook
Natera Inc. (NASDAQ: NTRA ) stock surged Friday after the genetic testing company reported second-quarter results that topped Wall Street estimates and raised its full-year revenue outlook, supported by strong oncology demand and continued momentum across its Women’s Health and Organ Health businesses. The company repo